BACKGROUND: Polycystic ovary syndrome (PCOS) is independently associated with the major cardiovascular risk factors. The aim of this study was to examine the echocardiographic profiles of patients with PCOS using conventional echocardiographic methods and tissue Doppler imaging. METHODS: For this study, we have registered 48 women with PCOS and 21 healthy control subjects who were matched with respect to age and body mass index. Standard two-dimensional and M-mode measurement, transmitral valve flows and tissue Doppler imaging of mitral and tricuspid anulus were recorded. RESULTS: In PCOS and control groups, left ventricular and atrium diameters, ejection fraction, mitral E/A ratio, deceleration time and isovolumic relaxation time were similar. There were no significant differences between patients with PCOS and control subjects with respect to tissue Doppler profiles. CONCLUSION: Patients with PCOS execute echocardiographic measures of cardiac function that are similar to those of healthy women.
BACKGROUND:Polycystic ovary syndrome (PCOS) is independently associated with the major cardiovascular risk factors. The aim of this study was to examine the echocardiographic profiles of patients with PCOS using conventional echocardiographic methods and tissue Doppler imaging. METHODS: For this study, we have registered 48 women with PCOS and 21 healthy control subjects who were matched with respect to age and body mass index. Standard two-dimensional and M-mode measurement, transmitral valve flows and tissue Doppler imaging of mitral and tricuspid anulus were recorded. RESULTS: In PCOS and control groups, left ventricular and atrium diameters, ejection fraction, mitral E/A ratio, deceleration time and isovolumic relaxation time were similar. There were no significant differences between patients with PCOS and control subjects with respect to tissue Doppler profiles. CONCLUSION:Patients with PCOS execute echocardiographic measures of cardiac function that are similar to those of healthy women.
Authors: Meri-Maija E Ollila; Kari Kaikkonen; Marjo-Riitta Järvelin; Heikki V Huikuri; Juha S Tapanainen; Stephen Franks; Terhi T Piltonen; Laure Morin-Papunen Journal: J Clin Endocrinol Metab Date: 2019-04-01 Impact factor: 5.958